↓ Skip to main content
What is this page? Embed badge

PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial

Overview of attention for article published in Investigational New Drugs, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
1 patent

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
40 Mendeley
Summary Policy documents X Patents Dimensions citations
So far, Altmetric has seen 1 patent that references this research output.

This page is provided by Altmetric.